D Miga1, R J Sokol, T Mackenzie, M R Narkewicz, D Smith, F M Karrer. 1. Pediatric Liver Center and Liver Transplantation Program, Section of Pediatric Gastroenterology, Hepatology and Nutrition, the Department of Pediatrics, University of Colorado School of Medicine and The Children's Hospital, Denver, Colorado 80218, USA.
Abstract
OBJECTIVE: To determine the influence of the new onset of esophageal variceal hemorrhage (EVH) on transplant-free survival in children with biliary atresia and to examine variables that predicted survival after the onset of EVH. METHODS: Retrospective chart review of 134 patients with biliary atresia who underwent portoenterostomy between 1973 and 1992 at a single institution; 29% had EVH. RESULTS: The risk of death or need for liver transplantation was 50% at 6 years after the initial episode of EVH. Patients with a serum bilirubin concentration < or =4 mg/dL at the first episode of EVH had transplant-free survival of >80% for 4 years after this episode, those with bilirubin levels >4 to 10 mg/dL had 50% survival at 1 year, and those with bilirubin levels >10 mg/dL had 50% survival at 4 months. The risk of death or transplant for a child with EVH and total serum bilirubin levels >10 mg/dL was 12.0 (95% CI: 6.0, 24.1), 4 to 10 mg/dL was 7.2 (3.1, 16.7), and < or =4 mg/dL was 0.6 (0.1, 3.1) times the risk of a same-aged child who did not have EVH. CONCLUSIONS: Children with biliary atresia and first EVH episode have a variable prognosis related to total serum bilirubin concentration at the time of the episode.
OBJECTIVE: To determine the influence of the new onset of esophageal variceal hemorrhage (EVH) on transplant-free survival in children with biliary atresia and to examine variables that predicted survival after the onset of EVH. METHODS: Retrospective chart review of 134 patients with biliary atresia who underwent portoenterostomy between 1973 and 1992 at a single institution; 29% had EVH. RESULTS: The risk of death or need for liver transplantation was 50% at 6 years after the initial episode of EVH. Patients with a serum bilirubin concentration < or =4 mg/dL at the first episode of EVH had transplant-free survival of >80% for 4 years after this episode, those with bilirubin levels >4 to 10 mg/dL had 50% survival at 1 year, and those with bilirubin levels >10 mg/dL had 50% survival at 4 months. The risk of death or transplant for a child with EVH and total serum bilirubin levels >10 mg/dL was 12.0 (95% CI: 6.0, 24.1), 4 to 10 mg/dL was 7.2 (3.1, 16.7), and < or =4 mg/dL was 0.6 (0.1, 3.1) times the risk of a same-aged child who did not have EVH. CONCLUSIONS:Children with biliary atresia and first EVH episode have a variable prognosis related to total serum bilirubin concentration at the time of the episode.
Authors: Simon C Ling; Thomas Walters; Patrick J McKiernan; Kathleen B Schwarz; Guadalupe Garcia-Tsao; Benjamin L Shneider Journal: J Pediatr Gastroenterol Nutr Date: 2011-03 Impact factor: 2.839
Authors: Sukru Emre; Christina Dugan; Tamara Frankenberg; Lisa Cooper Hudgins; Rosemarie Gagliardi; A Tarik Artis; Gonzalo Rodriguez-Laiz; Gabriel Gondolesi; Benjamin L Shneider; Nanda Kerkar Journal: HPB (Oxford) Date: 2009-05 Impact factor: 3.647
Authors: Benjamin L Shneider; Bob Abel; Barbara Haber; Saul J Karpen; John C Magee; Rene Romero; Kathleen Schwarz; Lee M Bass; Nanda Kerkar; Alexander G Miethke; Philip Rosenthal; Yumirle Turmelle; Patricia R Robuck; Ronald J Sokol Journal: J Pediatr Gastroenterol Nutr Date: 2012-11 Impact factor: 2.839